tiprankstipranks
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market
4570
Immuno-Biological Laboratories Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4570 full AI Analyst Report?

Immuno-Biological Laboratories Co., Ltd. (4570) Financial Statements

0 Followers

Immuno-Biological Laboratories Co., Ltd. Financial Overview

Immuno-Biological Laboratories Co., Ltd.'s market cap is currently ¥9.02B. The company's EPS TTM is ¥27.81; its P/E ratio is 26.95; Immuno-Biological Laboratories Co., Ltd. is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 1.00B¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M
Gross Profit¥ 700.28M¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M
Operating Income¥ 281.28M¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M
EBITDA¥ 299.82M¥ 226.55M¥ 128.11M¥ -279.54M¥ -249.50M
Net Income¥ 329.01M¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M
Balance Sheet
Cash & Short-Term Investments¥ 989.47M¥ 825.73M¥ 734.14M¥ 614.16M¥ 508.35M
Total Assets¥ 2.16B¥ 1.85B¥ 1.62B¥ 1.43B¥ 1.71B
Total Debt¥ 177.09M¥ 204.23M¥ 235.98M¥ 234.99M¥ 234.00M
Net Debt¥ -812.38M¥ -621.50M¥ -498.15M¥ -379.17M¥ -274.35M
Total Liabilities¥ 311.75M¥ 332.03M¥ 354.25M¥ 355.72M¥ 336.99M
Stockholders' Equity¥ 1.84B¥ 1.51B¥ 1.27B¥ 1.08B¥ 1.37B
Cash Flow
Free Cash Flow¥ 267.68M¥ 123.83M¥ 115.11M¥ 26.46M¥ -93.20M
Operating Cash Flow¥ 301.09M¥ 183.50M¥ 133.78M¥ 26.46M¥ -93.20M
Investing Cash Flow¥ -116.46M¥ -53.66M¥ -24.50M¥ 30.04M¥ -155.63M
Financing Cash Flow¥ -27.14M¥ -31.75M¥ 991.00K¥ 991.00K¥ 144.00M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History

Income Statement >

Immuno-Biological Laboratories Co., Ltd. Debt to Assets

Balance Sheet >

Immuno-Biological Laboratories Co., Ltd. Cash Flow

Cash Flow >

Immuno-Biological Laboratories Co., Ltd. Forecast EPS vs Actual EPS

Earnings >